Baxter - 39 Year Stock Price History | BAX

Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of September 28, 2020 is 79.54.
  • The all-time high Baxter stock closing price was 94.14 on April 20, 2020.
  • The Baxter 52-week high stock price is 95.19, which is 19.7% above the current share price.
  • The Baxter 52-week low stock price is 69.10, which is 13.1% below the current share price.
  • The average Baxter stock price for the last 52 weeks is 85.09.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Baxter Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 85.8929 85.8700 94.1400 71.5700 79.5400 -4.88%
2019 79.7233 65.3000 89.7800 64.4800 83.6200 27.04%
2018 69.8944 67.1700 77.8000 61.4500 65.8200 1.83%
2017 58.0264 44.4400 66.0500 44.4400 64.6400 45.78%
2016 43.8994 37.1700 49.1600 34.7600 44.3400 16.23%
2015 52.9969 73.3100 73.3100 32.2700 38.1500 -47.95%
2014 72.2730 69.1900 77.0000 66.4900 73.2900 5.38%
2013 69.3542 67.6500 74.4300 63.8900 69.5500 4.34%
2012 58.0275 50.5400 68.8100 49.0300 66.6600 34.72%
2011 54.3502 50.5500 62.4100 47.6500 49.4800 -2.25%
2010 49.9003 58.2900 61.7100 40.4700 50.6200 -13.74%
2009 54.0204 55.0800 60.5000 46.4100 58.6800 9.50%
2008 61.4454 57.7900 71.1500 48.5000 53.5900 -7.68%
2007 54.7795 46.5000 61.0900 46.3300 58.0500 25.13%
2006 40.9353 38.3600 47.2100 35.4500 46.3900 23.21%
2005 37.2682 34.6200 40.9500 33.3700 37.6500 9.00%
2004 31.4834 30.1700 34.5900 28.7600 34.5400 13.17%
2003 26.5806 28.6900 31.2000 18.5600 30.5200 9.00%
2002 43.1442 53.1000 59.6000 24.2200 28.0000 -47.79%
2001 48.4272 44.8150 55.5000 40.7500 53.6300 21.46%
2000 35.8150 30.6900 44.4400 25.9050 44.1550 40.60%
1999 32.7239 31.5950 37.9700 29.3450 31.4050 -2.24%
1998 28.6442 25.0650 33.0000 24.3450 32.1250 27.38%
1997 25.1378 20.3150 29.7500 20.3150 25.2200 23.02%
1996 21.9332 20.8100 23.9375 20.0000 20.5000 -2.10%
1995 17.7909 14.0650 21.2500 13.5650 20.9400 46.95%
1994 12.7748 12.1900 14.3150 11.0000 14.2500 16.90%
1993 13.4814 15.9400 15.9400 10.1250 12.1900 -24.71%
1992 17.9988 19.6250 20.0650 15.3750 16.1900 -19.05%
1991 16.9144 13.6900 20.1900 12.8150 20.0000 43.47%
1990 12.3140 12.7500 14.5000 10.3150 13.9400 11.52%
1989 10.7476 8.8100 12.8100 8.8100 12.5000 41.88%
1988 10.3560 11.6850 12.9350 8.2500 8.8100 -22.55%
1987 12.1138 9.5000 14.5600 9.1850 11.3750 18.18%
1986 9.0744 7.7500 10.5600 7.6250 9.6250 22.22%
1985 7.3046 6.5650 8.3100 6.2500 7.8750 19.95%
1984 8.1495 11.6250 12.2500 6.0000 6.5650 -43.53%
1983 13.3763 11.5925 15.6575 10.6850 11.6250 -3.89%
1982 9.6983 8.5625 12.6250 7.8125 12.0950 44.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $40.316B $11.362B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $183.161B 34.37
Medtronic (MDT) Ireland $138.669B 26.12
Stryker (SYK) United States $76.844B 29.80
Boston Scientific (BSX) United States $53.421B 30.86
Lonza Group Ag (LZAGY) Switzerland $45.798B 0.00
Terumo (TRUMY) Japan $30.009B 38.36
Zimmer Biomet Holdings (ZBH) United States $27.960B 23.20
EssilorLuxottica Societe Anonyme (ESLOY) France $27.740B 0.00
ResMed (RMD) United States $24.494B 35.51
Sunny Optical Technology (SNPTF) China $16.508B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.353B 0.00
Bio-Rad Laboratories (BIO) United States $14.962B 67.67
Insulet (PODD) United States $14.703B 622.11
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.255B 43.73
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.174B 10.60
Hill-Rom Holdings (HRC) United States $5.465B 13.56
Canopy Growth (CGC) Canada $5.268B 0.00
Haemonetics (HAE) United States $4.417B 29.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.388B 0.00
Neogen (NEOG) United States $3.998B 65.56
ICU Medical (ICUI) United States $3.904B 29.79
Envista Holdings (NVST) United States $3.806B 25.96
Abcam (ABCZY) $3.251B 0.00
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.118B 0.00
National Vision Holdings (EYE) United States $2.964B 460.63
NuVasive (NUVA) United States $2.522B 35.15
Agios Pharmaceuticals (AGIO) United States $2.380B 0.00
AtriCure (ATRC) United States $1.800B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.692B 0.00
NanoString Technologies (NSTG) United States $1.660B 0.00
Cardiovascular Systems (CSII) United States $1.446B 0.00
MacroGenics (MGNX) United States $1.355B 0.00
Owens & Minor (OMI) United States $1.299B 29.09
Aphria (APHA) Canada $1.221B 0.00
InMode (INMD) Israel $1.154B 29.10
Cerus (CERS) United States $1.010B 0.00
Quanterix (QTRX) United States $0.932B 0.00
PetIQ (PETQ) United States $0.912B 26.16
BioLife Solutions (BLFS) United States $0.840B 437.50
Lantheus Holdings (LNTH) United States $0.815B 11.30
OraSure Technologies (OSUR) United States $0.804B 0.00
Phibro Animal Health (PAHC) United States $0.722B 16.52
Meridian Bioscience (VIVO) United States $0.707B 16.34
LeMaitre Vascular (LMAT) United States $0.687B 41.95
Vapotherm (VAPO) United States $0.642B 0.00
Aurora Cannabis (ACB) Canada $0.583B 0.00
Zynex (ZYXI) United States $0.580B 50.61
Eagle Pharmaceuticals (EGRX) United States $0.566B 80.02
Omeros (OMER) United States $0.551B 0.00
Surmodics (SRDX) United States $0.522B 57.22
VAREX IMAGING (VREX) United States $0.472B 20.46
Viemed Healthcare (VMD) United States $0.341B 12.19
Cytosorbents (CTSO) United States $0.340B 0.00
HEXO (HEXO) $0.318B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.34
Surface Oncology (SURF) United States $0.252B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.241B 0.00
Organigram Holdings (OGI) Canada $0.204B 0.00
Female Health (VERU) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.164B 0.00
Chimerix (CMRX) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.141B 12.46
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.130B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.084B 0.00
Rockwell Medical (RMTI) United States $0.075B 0.00
United-Guardian (UG) United States $0.069B 15.40
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
Nephros (NEPH) United States $0.058B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.09
ImmuCell (ICCC) United States $0.040B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Senestech (SNES) United States $0.005B 0.00